Rx only · Injection, Solution · Intravenous

Valproate Sodium

2 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US2 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCN03AG01

RxCUI (US)11118

US makers2 labelers

Packages3

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

465

Rx · 2026 Q1

13K

Units dispensed

+134%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Fresenius Kabi USA, LLC	unknown	2	SUPPLYING
Sagent Pharmaceuticals	unknown	1	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Dec 30, 2020
SHORTAGEDrug shortage: Valproate Sodium Injection (Fresenius Kabi USA, LLC)
Valproate Sodium Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Neurology.